Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassila

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Thrombosis and Haemostasis|November 1, 2000
Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-AU Wartiovaara, H Mikkola, G Szôke, et al.
Thrombosis Research|January 1, 2021
Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patientsN Mattila, Y Hisada, B Przybyla, et al.
Journal of Internal Medicine|February 12, 2009
Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged menL Jartti, T Rönnemaa, O T Raitakari, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2014
Managing haemophilia for life: 4th Haemophilia Global SummitJ Astermark, G Dolan, T Hilberg, et al.
Thrombosis Research|January 4, 2011
EUHASS: The European Haemophilia Safety Surveillance systemM Makris, G Calizzani, K Fischer, et al.
Thrombosis and Haemostasis|July 31, 1998
Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activationU Wartiovaara, P Salven, H Mikkola, et al.
Thrombosis and Haemostasis|June 12, 1999
Function of glycoprotein VI and integrin alpha2beta1 in the procoagulant response of single, collagen-adherent plateletsJ W Heemskerk, P Siljander, W M Vuist, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome dataM Richards, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 29, 2009
FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendationsD Perry, E Berntorp, C Tait, et al.
Thrombosis and Haemostasis|February 4, 2010
A small-molecule inhibitor of integrin alpha2 beta1 introduces a new strategy for antithrombotic therapyL Nissinen, O T Pentikäinen, A Jouppila, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Thrombosis and Haemostasis|November 1, 2000
Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-AU Wartiovaara, H Mikkola, G Szôke, et al.
Thrombosis Research|January 1, 2021
Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patientsN Mattila, Y Hisada, B Przybyla, et al.
Journal of Internal Medicine|February 12, 2009
Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged menL Jartti, T Rönnemaa, O T Raitakari, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2014
Managing haemophilia for life: 4th Haemophilia Global SummitJ Astermark, G Dolan, T Hilberg, et al.
Thrombosis Research|January 4, 2011
EUHASS: The European Haemophilia Safety Surveillance systemM Makris, G Calizzani, K Fischer, et al.
Thrombosis and Haemostasis|July 31, 1998
Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activationU Wartiovaara, P Salven, H Mikkola, et al.
Thrombosis and Haemostasis|June 12, 1999
Function of glycoprotein VI and integrin alpha2beta1 in the procoagulant response of single, collagen-adherent plateletsJ W Heemskerk, P Siljander, W M Vuist, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome dataM Richards, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 29, 2009
FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendationsD Perry, E Berntorp, C Tait, et al.
Thrombosis and Haemostasis|February 4, 2010
A small-molecule inhibitor of integrin alpha2 beta1 introduces a new strategy for antithrombotic therapyL Nissinen, O T Pentikäinen, A Jouppila, et al.
Pageof 10